acastipharma.com - ACST Quarterly EPS earnings growth

Symbol and logo of brand acastipharma.com (ACST)

Acasti Pharma (ACST) relies on innovative drug delivery methods to combat rare pathologies. Patent protection of formulas curbs competition, although a capital deficit weakens the firm's position. Geopolitical tensions and disruptions in reagent supplies are hindering global tests. The quarterly percentage change in EPS reflects net profit dynamics, where the current value is 56.20, revealing the margin's resilience to costs.

ACST: Acasti Pharma Inc. Year-over-year earnings per one share growth for the last 12 months 07/04/2022 - 10/28/2024

Acasti Pharma (ACST) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Stock Quotes acastipharma.com|ACST - Analyst Forecast Prices
- issuer market value details:
Market Capitalization Acasti|ACST - Company Buyout Price
- balance sheet net asset value indicators:
Accounting Value per Share Acasti Pharma|ACST - Accounting Value of Company|Market Value to Book Value Ratio acastipharma.com|ACST - Total Asset Value of Company
- debt level and financial liquidity data:
Total Debt to Capital Acasti Pharma|ACST - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital acastipharma.com|ACST - Company Aggregate Debts|Debt to Book Capitalization Ratio Acasti|ACST - Company Long-Term Loans and Borrowings|Company Short-Term Debt Acasti Pharma|Quick Ratio acastipharma.com
- earnings and valuation multiples information:
ACST - Net Profit|Projected Future Earnings Acasti Pharma|ACST - P/E Multiple|Forward P/E Multiple acastipharma.com|ACST - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Acasti|ACST - Operating income before deduction of amortization|Net earnings per share for the last 12 months Acasti Pharma|ACST - Earnings per share for the last four quarters|Quarterly EPS earnings growth acastipharma.com|ACST - Earnings per share increase in current year|Earnings growth forecast for next year Acasti Pharma
- sales revenue and business income indicators:
ACST - Company Total Revenue|Projected Sales Volume acastipharma.com|ACST - P/S Multiple|Price-to-Projected Revenue Ratio Acasti
Initial company analysis:Acasti Pharma
Flagship merchandise of Acasti Pharma

Quarterly EPS growth measures the dynamics of net income per share compared to the same period last year, reflecting the efficiency of value generation for shareholders. Analyzing the current quarterly EPS rate allows for an assessment of how licensing revenues and Acasti Pharma (ACST) developments in treating cardiac pathologies can ensure the business's financial stability amidst market volatility.

Who Acasti Pharma competes with

REGN (Regeneron) - Year-over-year net earnings per share growth for the last 12 months|IRTC: Year-over-year earnings per share growth rate for the last twelve months|LNTH (Lantheus Medical Imaging) - Quarterly EPS earnings growth|Mineralys Corp (MLYS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HTFL (HeartFlow)|KMTS (kestramedical.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Esperion ESPR|AMRN (Amarin Corporation) - Year-over-year net earnings per share trend for the last twelve months|Anteris Technologies Ltd - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TNYA (Tenaya Therapeutics)|CVRX: Quarterly EPS earnings growth|milestonepharma.com (MIST) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Cardiol Therapeutics Inc|BEAT: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Tenax Therapeutics, Inc (TENX)|Year-over-year net earnings per share growth for the last 12 months Adagio Medical, Inc. ADGM|Quarterly EPS earnings growth BCDA (BioCardia, Inc.)|Quarterly EPS earnings growth catheterprecision.com VTAK|ARCA Bio - Quarterly EPS earnings growth|AVTE - Quarterly EPS earnings growth|VERV: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Windtree Therapeutics, Inc.